Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 11, 2019 at 09:01 pm
Share
Yung Zip Chemical Ind. Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 111.484 million compared to TWD 78.508 million a year ago. Operating income was TWD 10.452 million compared to operating loss of TWD 9.212 million a year ago. Net income was TWD 11.959 million compared to net loss of TWD 6.143 million a year ago. Basic earnings per share was TWD 0.28 compared to basic loss per share of TWD 0.14 a year ago. For the half year, sales was TWD 214.289 million compared to TWD 149.392 million a year ago. Operating income was TWD 17.352 million compared to operating loss of TWD 15.049 million a year ago. Net income was TWD 19.024 million compared to net loss of TWD 12.060 million a year ago. Basic earnings per share was TWD 0.45 compared to basic loss per share of TWD 0.28 a year ago.
YUNG ZIP CHEMICAL IND. CO., LTD. is a Taiwan-based company principally engaged in the manufacturing and trading of pharmaceutical ingredient products. Its diclofenac sodium (DCS) is used for the treatment of rheumatoid arthritis, bursitis and inflammation. The acyclovir (ACV) is used for the treatment of herpes virus infections. The miconazole nitrate (MCN) is used for the treatment of yeast infection. The sodium starch glycolate (SSG) is used as disintegrant in pharmaceutical preparation. The Clonidine hydrochloride (CLD) is used for the treatment of hypertension. The Company mainly distributes its products in domestic market and overseas markets, including the United States of America (the USA), Thailand, Indonesia and the Philippines.
YUNG ZIP CHEMICAL IND. CO., LTD. 